The iShares 3-7 Year Treasury Bond ETF is sensitive to yield curve changes, making it risky amid rising inflation expectations and disappointments regarding rate cuts. IEI's irregular maturity profile increases costs unnecessarily; cheaper alternatives with similar duration exposures exist, making IEI specifically uninteresting. The bond market's optimism on rate reductions may be misplaced, as rising inflation expectations and partial oil price recovery could force the Fed to prioritize inflation control.

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors that a shareholder filed a class action on behalf of purchasers of common stock of Ready Capital Corporation (NYSE: RC) between November 7, 2024 and March 2, 2025. Ready Capital describes itself as a real estate finance company. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigating the Allegations that Read.

RADNOR, Pa.--(BUSINESS WIRE)-- #classaction--The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that securities class action lawsuits have been filed against Geron Corporation (“Geron”) (NASDAQ: GERN) on behalf of those who purchased or otherwise acquired Geron securities between February 28, 2024, and February 25, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is May 12, 2025. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Geron losses,.

Leadership in e-commerce and cloud remains intact, which is vital for future growth, as both markets are poised to deliver 16%+ CAGR over the long term. The management continues to demonstrate a strong commitment to expanding profitability, as reinforced by the CEO's recent letter to shareholders. My valuation analysis suggests that AMZN stock is more than 50% undervalued prior to the upcoming earnings release.

Warren Buffett's Berkshire Hathaway sold more stock than it bought in 2024, so it likely raised some eyebrows when the company revealed its position in Constellation Brands (STZ -1.10%).

It's always a good time to buy solid dividend stocks, but considering the challenging economic environment, now might be a particularly opportune time. Dividend-paying companies tend to have strong underlying operations and are generally more resilient than their non-dividend-paying counterparts.

Archer Aviation (ACHR 0.35%) has built a futuristic airplane that can now be seen buzzing around test sites. Buzzing is an apt description because the small passenger planes take off and land vertically and are meant to operate only over short distances.

Cemig is the biggest energy distributor of Latin America. Upcoming regulatory changes will end Cemig's privileged market position, shrinking its main captive market segment and opening it up competition. Despite delivering record results, the company is already showing signs of weakness, with lower recurring revenues.

Palantir (PLTR 4.63%) stock has pulled back, but a hidden catalyst could change everything. In this video, you'll discover Palantir's secret weapon that could send its stock soaring despite its sky-high valuation.

CG Oncology Announces Best-in-Disease Durability Data in BOND-003 Cohort C and Promising Early Signal in Cohort P for Cretostimogene Grenadenorepvec at AUA

OpenAI, Perplexity AI and Yahoo have expressed interest in buying Chrome, as Google's legal battle escalates. Here's what it could mean for the future of the web.

E-commerce giant Amazon (Nasdaq: AMZN) is one of the largest companies and is the world's biggest cloud computing service provider.

Estee Lauder stock price has been in a free fall in the past few years as the company's growth waned. EL has declined by over 83% from its peak in 2021, underperforming other companies in the consumer staples and discretionary sectors.

NEW YORK, April 26, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today announced that one of its scientific co-founders, Mads Hald Andersen, DMSc, PhD, Director of the National Center for Cancer Immune Therapy (CCIT-DK), chaired and presented at an educational session on cancer vaccines at the 2025 American Association for Cancer Research (AACR) Annual Meeting. The session brought together leading oncology scientists and explored the latest advancements in cancer vaccine research, from preclinical innovation to clinical implementation, providing perspective on the future of cancer vaccines and their potential …

Larry Fink, the CEO of BlackRock (NYSE: BLK), recently suggested that the 60/40 portfolio model needed to be replaced by a 50/30/20 portfolio. The new 20% portion is dedicated to things like infrastructure and real estate.

I'm not going to sugarcoat this: Machine vision company Cognex (CGNX 0.27%) is heading for a tough year, and there's a substantial risk that management won't have great news for investors when it delivers its first-quarter earnings on April 30. On the other hand, the stock looks like an excellent value for long-term investors searching for a growth stock to buy and hold for decades to come.

It's been a wild start to the year for Lucid Group (LCID 1.84%) investors. Founder and former CEO Peter Rawlinson resigned and will take on a consulting role.

ExxonMobil (XOM -0.03%) believes that carbon capture and sequestration (CCS) represents a massive opportunity to make money while helping the environment. The oil giant believes the market for CCS will be worth a staggering $4 trillion by 2050.

The stock market has entered a new period of increased uncertainty and volatility following the Trump Administration's desire to reshape America's trade policies. While the market hasn't crashed outright, it has experienced multiple sessions of sharp losses, as well as dramatic rebounds.

Many investors are withdrawing their money from the stock market right now, but those focused on the long term know to hold on through market volatility. In fact, it's still a great time to invest in companies that have excellent underlying businesses and attractive long-term prospects.